July 28, 2016
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Russell Mancuso
Re: Cesca Therapeutics Inc.
Registration Statement on Form S-3(FileNo.333-212314)
Acceleration Request
Requested Date: August 1, 2016
Requested Time: 4:00 p.m. (Eastern Time)
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request that the Securities and Exchange Commission (the “Commission”) accelerate the effectiveness of the above-referenced Registration Statement on behalf of Cesca Therapeutics Inc. (the “Company”) to become effective on the “Requested Date” at the “Requested Time” set forth above, or at such later date and time as we may advise the Commission orally or in writing, or as soon thereafter as practicable.
The Company hereby acknowledges that:
• should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
• the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
• the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
The Company also requests that the Commission confirm the effective date and time of the Registration Statement in writing.
| Sincerely, |
| |
CESCA THERAPEUTICS INC. | |||
|
|
|
|
|
|
|
|
| By: | /s/ Robin Stracey |
|
|
| Robin Stracey |
|
|
| Chief Executive Officer |
|
